No Data
HitGen Inc. (SHSE:688222) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Chengdu Pilot Drug Development Co., Ltd. Report for the Third Quarter of 2024
hitgen inc. (688222.SH) announced its performance for the first three quarters, with a net income of 30.12 million yuan, a year-on-year increase of 64.71%.
hitgen inc. (688222.SH) disclosed the third quarter report of 2024, achieving revenue of 2....
hitgen inc. (688222.SH): The profit for the first three quarters was 30.12 million yuan, a year-on-year increase of 64.71%.
Gelonghui October 25th 丨 hitgen inc. (688222.SH) released its third-quarter report, with a revenue of 0.298 billion yuan in the first three quarters, a year-on-year increase of 21.38%, a net income of 30.12 million yuan, a year-on-year increase of 64.71%, a non-net profit of 17.31 million yuan, a year-on-year increase of 6831.94%, and an eps of 0.08 yuan.
Hitgen Inc. (688222.SH): Its wholly-owned subsidiary in the United Kingdom received a government subsidy of 1.0499 million British pounds.
According to Gelonghui on September 12th, HitGen Inc. (688222.SH) announced that its wholly-owned subsidiary Vernalis (R&D) Limited in the United Kingdom recently received government grants of 1.0499 million British pounds (equivalent to 949.23 million. 95 yuan in RMB), all of which are government grants related to income.
HitGen's (SHSE:688222) Earnings Offer More Than Meets The Eye
Time To Worry? Analysts Are Downgrading Their HitGen Inc. (SHSE:688222) OutlookNo Data
No Data
